Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Jan Rehwinkel, Principal Investigator in the MRC Human Immunology Unit, who delivered his Lister Institute Research Fellowship Prize Lecture on 3 May.

Jan shared his research into nucleotide sensing by the immune system, including new work funded by the Lister Institute to investigate detection of DNA and RNA in the ‘Z confirmation’ in anti-viral responses.

We were delighted to welcome representatives from the Lister Institute, including Prof Sir Alex Markham – chair of the Lister Institute Governing Body – who presented Jan with his Prize.

Similar stories

Funding awarded for autoimmune disease research

Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.

MRC National Mouse Genetics Network Research Clusters Announced

Claus Nerlov and Steve Twigg from the MRC WIMM join the new national network for disease modelling.

RDM announces new Principal Investigators

Dr Stephen Twigg has been announced as one of eight new Principal Investigators by the Radcliffe Department of Medicine.

Defining the role of resident memory B cells in the fight against influenza

Researchers at the Kennedy Institute of Rheumatology and the MRC Human Immunology Unit have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.

Patient priorities guide Oxford Myeloma research

Medical staff in Oxford are partnering closely with Myeloma patients to help set priorities for future research.

From ‘Ew, gross!’ to ‘Wow!’: Scientists bring immunology to the classroom

For British Science Week, members of the MRC WIMM visited a local Oxfordshire primary school for an interactive science day – one of the first of its kind since the start of the pandemic.